Netherlands Cancer Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Netherlands Cancer Institute
Feb 4, 2025, 16:11 | Career
Jos Jonkers - Candidate for the Nominating Committee of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote…
Oct 9, 2024, 10:32 | Blog
Winan van Houdt: Welcoming guest surgeons from Prague and Cali to share knowledge on sarcoma and melanoma
Winan van Houdt posted the following on LinkedIn: “It is a pleasure to welcome our…
Oct 5, 2024, 09:26 | Blog
Emily Holthuis: Expanding Partnerships with Patients and Carers in the EORTC
Emily Holthuis, PhD student at the Netherlands Cancer Institute, shared a post on X: "It…
Sep 24, 2024, 08:26 | Blog
Winette Van Der Graaf: Moving precision oncology from research to clinical practice for rare cancers
Winette Van Der Graaf shared a post on X: "Such a great pleasure to have…
Sep 15, 2024, 15:11 | Insight
Myriam Chalabi's highlights from ESMO24
The ESMO Congress 2024 (ESMO24) is one of the most globally influential platforms in oncology, bringing…
Sep 6, 2024, 10:48 | Blog
OncoInfluencers to Follow on Social Media: Dr. Myriam Chalabi
We are thrilled to highlight Dr. Myriam Chalabi as a key figure in the oncology…
Aug 14, 2024, 06:28 | Insight
Myriam Chalabi: Management of Locally Advanced Rectal Cancer: - ASCO Guideline
Myriam Chalabi shared on X: "Now online in the Journal of Clinical Oncology! Management of…
Aug 6, 2024, 16:11 | Insight
Daniel Peeper: Therapeutic approaches combined with PD1 axis blockade to provide synergistic clinical benefit
Daniel Peeper, Head of the Division of Molecular Oncology and Immunology at the Netherlands Cancer…
Jul 31, 2024, 11:44 | Insight
Michiel van der Heijden: Explaining inconsistent results in urothelial cancer with chemo plus IO
Michiel van der Heijden, Medical Oncologist at Netherlands Cancer Institute, shared on X: "Results of…
Jul 27, 2024, 22:17 | Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 25, 2024, 08:58 | Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 13, 2024, 20:21 | Blog
Antoni van Leeuwenhoek has been awarded with grant of 4.1 million eur
Marleen Kok shared Antoni van Leeuwenhoek's post on LinkedIn, adding: "Incredibly proud of my team…
Jul 12, 2024, 13:45 | Insight
Outstanding scientists elected to EMBO Membership
EMBO (European Molecular Biology Organization) is a European organization of 2,000+ researchers that promotes excellence in…
Jul 3, 2024, 21:35 | Insight
Understanding the prediagnostic journey experienced by sarcoma patients
Emily Holthuis, PhD student at the Netherlands Cancer Institute, shared on LinkedIn: "I'm excited to…
Jul 2, 2024, 07:19 | Societies
25 Posts You Should Not Miss From ESMOGI24!
ESMOGI24 took place as an onsite event in Munich, Germany, from 26 to 29 June…
Jul 2, 2024, 03:02 | Blog
Myriam Chalabi: Patients with stage 1c TNBC with high TILs have an excellent prognosis without chemo
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 30, 2024, 08:07 | Societies
9 Posts You Should Not Miss From Day 3 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 28, 2024, 11:28 | Societies
Keynote address by Myriam Chalabi at ESMOGI24
Toni Choueiri shared on X: "Keynote address at ESMOGI24 with superstar Myriam Chalabi- Immunotherapy for…
Jun 28, 2024, 09:48 | Societies
Mark Lewis: Thank you for what you are doing for our field, Myriam Chalabi
Mark Lewis shared on X: "Ok, I’ll admit I’m star-struck. Not every day you meet…
Jun 22, 2024, 01:53 | Blog
Herbert Loong: Pleased to welcome Prof. Rick Haas as the plenary speaker of our 6th CUHK Sarcoma Masterclass
Herbert Loong shared a post on LinkedIn:     . “We were pleased to welcome Prof. Rick…
Jun 10, 2024, 03:19 | Blog
Myriam Chalabi: What a week it has been for neoadjuvant immunotherapy
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Netherlands Cancer Institute, shared a post…
Jun 2, 2024, 23:47 | Insight
NADINA is one of the 11 clinical studies with the biggest impact on health care in 2024 - Netherlands Cancer Institute
Quoting The Netherlands Cancer Institute on LinkedIn: "The NADINA study, led by researchers from the…
May 19, 2024, 18:27 | Blog
Winan van Houdt: Speaking at the annual national AYA conference
Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek, the Netherlands Cancer Institute, shared on…
May 16, 2024, 06:01 | Blog
Emily Holthuis: I shared initial findings from the QUEST study during the Dutch Sarcoma Group Research Day
Emily Holthuis, PhD student at Netherlands Cancer Institute, shared a post on X: “Yesterday, I…
May 4, 2024, 07:02 | Blog
Myriam Chalabi: Looking forward to reading all the exciting lower GI abstracts!
Myriam Chalabi shared  a post by ESMO on X, adding: "May 7th. ESMO24 deadline! Looking…
Apr 26, 2024, 11:57 | Blog
Myriam Chalabi: What happens in Zurich….goes to ESMO25
Myriam Chalabi shared on X/Twitter: ''What happens in Zurich….goes to ESMO25! Fantastic meeting and discussions…
Apr 24, 2024, 22:30 | Blog
Rene H. Medema: I’m starting a new position as Driector of Research at Prinses Máxima Centre for Pediatric Oncology!
Rene H. Medema, Director of Research at Netherlands Cancer Institute, shared a post on LinkedIn: "I’m…
Nov 13, 2023, 13:18 | Career
The Connective Tissue Oncology Society (CTOS) – has awarded the Lifetime Achievement Award to Professor Rick Haas - Antoni van Leeuwenhoek
Antoni van Leeuwenhoek Hospital shared on LinedIn: "The global scientific society dedicated to sarcoma patients…
Oct 1, 2023, 12:45 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 6
In August, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion Leaders…
All: 29 Posts: 1 - 100
Special Coverage